What does Be Swasth Healthcare Limited do?

Be Swasth Healthcare Limited has pivoted from being a Non-Banking Financial Company (NBFC) to operating in the healthcare and telemedicine space. The company surrendered its RBI NBFC licence on August 2, 2018, and has reoriented its business towards digital health services.

Was Be Swasth Healthcare Limited always in healthcare?

No. The company was originally registered as an NBFC with the Reserve Bank of India and operated in financial services. It voluntarily surrendered its NBFC licence in August 2018 and subsequently pivoted to the healthcare and telemedicine sector.

Is Be Swasth Healthcare Limited listed on a stock exchange?

No, Be Swasth Healthcare Limited is an unlisted public limited company based in Delhi. Its shares are available only in the unlisted/pre-IPO secondary market at approximately ₹13.25 per share.

When was Be Swasth Healthcare Limited incorporated?

The company was incorporated in 1985, as indicated by its CIN L93000DL1985PLC021397, making it over 40 years old.

What is the significance of the NBFC licence surrender in 2018?

Voluntarily surrendering the RBI NBFC registration in August 2018 marked the company's formal exit from the financial services sector and its transition to healthcare. This was a proactive regulatory action, not a forced cancellation, indicating compliance and strategic intent.

Is Be Swasth Healthcare planning an IPO?

There is no publicly confirmed IPO plan for Be Swasth Healthcare Limited. Investors should monitor MCA filings and official announcements for any developments.

How do I buy Be Swasth Healthcare unlisted shares here?

Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.

Who am I actually transacting with?

You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.

How do I pay, and is there a payment gateway?

Payment is by direct bank transfer to Prospire Network Private Limited's published account (CIN U82300UP2025PTC233622), shown to you in-app at the payment step. There is no card gateway and no escrow. Never pay to a personal account or to any account shared over phone, WhatsApp or email — even if the person claims to be from our team.

How long does settlement take?

After you accept an allocation, you have a short window to pay (typically 2 days). Once payment is verified, shares are usually credited to your demat within 2–3 business days, subject to depository timelines and any company-level restrictions. Timeframes are typical, not guaranteed.

There are no separate platform fee lines and no GST on the transfer — the desk's margin is built into the buy/sell price you're quoted. The only statutory add-on on a purchase is stamp duty on the consideration, shown transparently in your cost breakdown.

Is there a minimum ticket size for Be Swasth Healthcare?

Minimums vary by company and depend on the lot the desk can source. Raise an enquiry and the desk will confirm the available quantity and the minimum for that name.

What KYC do I need, and do I need a demat account?

You'll share your demat details when you enquire so we can settle directly. Full KYC — PAN and a client-master / demat statement — is required before the transfer step, when shares actually change hands. Yes, you need an active demat account to hold unlisted shares.

Are there lock-ins on unlisted or pre-IPO shares?

Some shares carry statutory or company-imposed lock-ins — for example, a post-listing lock-in on pre-IPO stock — and transfers can be subject to the company's articles or approvals. Where a lock-in applies, we'll flag it before you commit.

How do I sell Be Swasth Healthcare shares I already hold?

Raise a sell enquiry with the company, quantity and your target price. The desk confirms a buying price, you transfer your shares into the desk's demat, and once the credit is verified we pay you out by bank transfer to your registered account. The desk never pays out before your shares are received.

Unlisted shares are illiquid, may be hard or impossible to sell, and are not covered by exchange settlement guarantees or investor-protection funds. Pricing is indicative, not live. Read the full Risk Disclosure before you enquire, and invest only what you can afford to lock away.

Be Swasth Healthcare Unlisted Share Price | Buy Be Swasth Healthcare Pre-IPO Shares — wisefolio

Investment Thesis

Be Swasth Healthcare Limited is a Delhi-based company that pivoted from NBFC to digital health in 2018. While the telemedicine sector offers significant growth opportunities, the company's ability to compete with established players and build genuine healthcare capabilities from scratch is unproven. With a share price of ₹13.25 and minimal public operational data, this is a high-risk, speculative investment. Due diligence via MCA filings and direct company engagement is strongly recommended before investing.

Pros

ISIN INE288U01011 confirmed; L-prefix CIN (L93000DL1985PLC021397) — listed, exchange-regulated company.
Pivoted to telemedicine/tele-health in 2020 — positioned in high-growth digital health segment post-COVID.
Active website at be-swasth.com; franchise model for telemedicine — scalable asset-light distribution approach.
Delhi NCR base — access to India's largest healthcare ecosystem and tech talent pool.

Cons

No revenue data publicly confirmed — financial scale unclear; likely pre-revenue or very early-stage in telehealth.
Telemedicine is intensely competitive: Practo, 1mg, Apollo 247, Tata 1mg, government e-Sanjeevani have dominant positions.
Paid-up capital only Rs.1.119 Cr (Rs.111.9 lakh) — very thin capital base for building a healthcare franchise network.
Originally incorporated 1985 in unrelated activities before 2020 telehealth pivot — execution track record in healthcare is limited.
Franchise model requires strong brand and training infrastructure; early-stage companies struggle with quality consistency.

Business Segments

Telemedicine / Tele-Health

Franchise-based telemedicine and tele-health services under Be Swasth brand; digital healthcare delivery model added 2020.

Revenue Model

Be Swasth Healthcare Limited appears to be transitioning to a digital health and telemedicine model. Revenue in this segment typically comes from patient consultation fees, subscription-based health plans, pharmacy tie-ups, and diagnostic service referral commissions. Given the recent pivot from NBFC, the exact revenue model and its current scale are not publicly confirmed.

Detailed Analysis

Growth outlookExpansion plans, industry tailwinds & headwinds9

Growth Plans

India's telemedicine market projected to grow significantly driven by Tier 2 and Tier 3 city healthcare demand

Government's Ayushman Bharat Digital Mission (ABDM) creating interoperable infrastructure for digital health players

Post-COVID-19 acceleration in patient acceptance of remote consultation models

Industry Tailwinds

India's telemedicine market projected to grow significantly driven by Tier 2 and Tier 3 city healthcare demand

Recent Developments

NBFC Licence Surrendered

Be Swasth Healthcare Limited voluntarily surrendered its Non-Banking Financial Institution (NBFC) registration with the Reserve Bank of India on August 2, 2018, completing its transition away from financial services.

2018-08

Comparable Companies

CompanyTypeTickerMkt Cap

Tata 1mg (unlisted subsidiary)Unlisted——

Practo Technologies (unlisted)Unlisted——

Apollo Hospitals Enterprise LimitedListedAPOLLOHOSP~90,000 Cr

Tata 1mg (unlisted subsidiary)Unlisted

Practo Technologies (unlisted)

Frequently Asked Questions

About Be Swasth Healthcare

Be Swasth Healthcare Limited is a Delhi-based public limited company that has pivoted to the digital health and telemedicine space. Originally incorporated on 6 March 1985, the company has reinvented itself to offer affordable telemedicine services, including online doctor consultations at prices as low as ₹10 per consultation — positioning itself in the accessible healthcare segment targeting India's underserved population. The company's telemedicine platform connects patients with doctors through a digital interface, enabling remote consultations without requiring physical visits to healthcare facilities. At ₹10 per consultation, Be Swasth aims to democratise healthcare access for low-income households in urban and rural India. This hyper-affordable pricing model is unusual in India's telemedicine space, where most platforms charge ₹200–500 per consultation, suggesting either a high-volume/low-margin model or significant cross-subsidisation. Be Swasth Healthcare has an authorised share capital of ₹5 crore and a paid-up capital of approximately ₹1.119 crore. The company's MCA filings are available up to FY2021, indicating some activity in recent years. However, the scale of operations and current traction of its digital health platform is not prominently disclosed in public databases. India's telemedicine sector saw significant acceleration post-COVID-19, with regulatory clarity provided by the Telemedicine Practice Guidelines 2020 issued by the Ministry of Health and Family Welfare. This regulatory framework legitimised remote consultations and created a structured environment for companies like Be Swasth to operate. The mass-market affordable telemedicine model has significant potential if the company can achieve distribution scale, though execution and sustainability of the ₹10 pricing model remain key questions.

Key Milestones

Incorporated July 2, 1985 in West Delhi (CIN: L93000DL1985PLC021397)

Common questions about unlisted shares

How do I buy Be Swasth Healthcare unlisted shares here?
Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.
Who am I actually transacting with?
You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.
How do I pay, and is there a payment gateway?

Be Swasth Healthcare Limited

How settlement works

Get price alerts for Be Swasth Healthcare Limited

Discuss Be Swasth Healthcare

Other ways to invest